Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Raguénès Odile"'
Publikováno v:
BMC Genetics, Vol 2, Iss 1, p 19 (2001)
Abstract Background R122, the primary autolysis site of the human cationic trypsinogen (PRSS1), constitutes an important "self-destruct" or "fail-safe" defensive mechanism against premature trypsin activation within the pancreas. Disruption of this s
Externí odkaz:
https://doaj.org/article/2bcb2ce8b65646a68f48dc2ace9b7291
Autor:
Chen, Jian-Min, Masson, Emmanuelle, Macek, Milan, Jr., Raguénès, Odile, Piskackova, Tereza, Fercot, Brigitte, Fila, Libor, Cooper, David N., Audrézet, Marie-Pierre, Férec, Claude
Publikováno v:
In Journal of Cystic Fibrosis 2008 7(1):37-43
Autor:
Mura, Catherine, Raguénes, Odile, Scotet, Virginie, Jacolot, Sandrine, Mercier, Anne-Yvonne, Férec, Claude
Publikováno v:
In Genetics in Medicine January 2005 7(1):68-73
Autor:
Chen, Jian–Min, Mercier, Bernard, Audrezet, Marie–Pierre, Raguenes, Odile, Quere, Isabelle, Ferec, Claude
Publikováno v:
In Gastroenterology March 2001 120(4):1061-1063
Autor:
Le Gac, Gérald, Mura, Catherine, Raguenes, Odile, Mercier, Anne-Yvonne, De Braekeleer, Marc, Férec, Claude
Publikováno v:
In Blood Cells, Molecules and Diseases August 2000 26(4):312-319
Autor:
Mura, Catherine, Le Gac, Gérald, Raguénes, Odile, Mercier, Anne-Yvonne, Le Guen, Alain, Férec, Claude
Publikováno v:
In Molecular Genetics and Metabolism April 2000 69(4):295-301
Autor:
Rivard, Sylvain R, Mura, Catherine, Simard, Hervé, Simard, Raynald, Grimard, Doria, Le Gac, Gérald, Raguenes, Odile, Férec, Claude, De Braekeleer, Marc
Publikováno v:
In Blood Cells, Molecules and Diseases February 2000 26(1):10-14
Publikováno v:
In Blood 15 April 1999 93(8):2502-2505
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Le Maréchal, Cedric, Chen, Jian-Min, Quéré, Isabelle, Raguénès, Odile, Férec, Claude, Auroux, Jean
Publikováno v:
BMC Genetics, Vol 2, Iss 1, p 19 (2001)
BMC Genetics
BMC Genetics
Background R122, the primary autolysis site of the human cationic trypsinogen (PRSS1), constitutes an important "self-destruct" or "fail-safe" defensive mechanism against premature trypsin activation within the pancreas. Disruption of this site by a